Skip to main content
OpenTrials

Clinical trial condition

HFmrEF

Explore clinical trials studying HFmrEF. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

HFmrEF trial results

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

NCT07147114

Conditions
Combined Pre- and Post-capillary Pulmonary Hypertension, CpcPH, Group 2 Pulmonary Hypertension, +2 more
Locations
  • Pusan National University Hospital Busan, South Korea
  • Chungbuk National University Hospital Chungju, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Chungnam National University Hospital Daejeon, South Korea
View all 15 locations
View Trial Details
Recruiting

US Benchmarking Clinical Study

NCT07215715

Conditions
ATTR-CM (Transthyretin Amyloid Cardiomyopathy), Amyloid Neuropathies, Amyloid Neuropathies, Familial, +25 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions